Clinical Trial Update: A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SG301, a CD38-targeting monoclonal antibody, given subcutaneously in children with nephrotic syndrome who have frequent relapses or ste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome
• Steroid-dependent Nephrotic Syndrome

Drugs mentioned

• SG301

Snippet

Sponsor: Mao Jianhua | Conditions: Nephrotic Syndrome in Children | Phase 2 | Status: RECRUITING